BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4576417)

  • 1. Controlled studies of metopimazine for the treatment of nausea and vomiting.
    Moertel CG; Reitemeier RJ
    J Clin Pharmacol; 1973 Jul; 13(7):283-7. PubMed ID: 4576417
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of nausea and vomiting related to anti-cancerous multiple combination chemotherapy: results of two controlled studies.
    Israel L; Rodary C
    J Int Med Res; 1978; 6(3):235-40. PubMed ID: 348536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double-blind study of alizapride in nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
    Viala JJ; Girard D; Cordier JF
    Sem Hop; 1982 Feb; 58(6):371-4. PubMed ID: 6280306
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy-induced nausea and vomiting with special emphasis on metopimazine.
    Herrstedt J
    Dan Med Bull; 1998 Sep; 45(4):412-22. PubMed ID: 9777292
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled clinical study of metopimazine and perphenazine in treatment of radiation nausea and vomiting.
    Chu FC; Paulshock M; Wallenstein SL; Houde RW; Phillips R
    Clin Pharmacol Ther; 1969; 10(6):800-9. PubMed ID: 4900201
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiemetic effects of ondansetron and metopimazine.
    Roila F; Ballatori E; Del Favero A
    N Engl J Med; 1993 Oct; 329(18):1356-7. PubMed ID: 8413427
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, double-blind trial assessing the efficacy and safety of sublingual metopimazine and ondansetron in the prophylaxis of chemotherapy-induced delayed emesis.
    Khamales S; Bethune-Volters A; Chidiac J; Bensaoula O; Delgado A; Di Palma M
    Anticancer Drugs; 2006 Feb; 17(2):217-24. PubMed ID: 16428941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double blind randomized trial of metopimazine: for postoperative nausea and vomiting after cholecystectomy].
    Rodary C; Elman A; Durand M; Cohen-Solal J; Maillard JN
    Ann Anesthesiol Fr; 1979; 20(2):118-20. PubMed ID: 38705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of metopimazine on gastric motility. Double-blind study using external digestive electromyography].
    Bertrand J; Thillier JL
    Nouv Presse Med; 1975 Oct; 4(32):2319-20. PubMed ID: 1101213
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy.
    Bloch J; Rixe O; Meric JB; Delgado A; Khayat D
    Curr Med Res Opin; 2005 Nov; 21(11):1763-71. PubMed ID: 16307696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-emetics.
    MacGregor EA
    Curr Med Res Opin; 2001; 17 Suppl 1():s22-5. PubMed ID: 12463273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for relief of nausea and vomiting.
    Med Lett Drugs Ther; 1974 May; 16(11):46-8. PubMed ID: 4151675
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral benzquinamide in the treatment of nausea and vomiting.
    Moertel CG; Schutt AJ; Hahn RG; O'Fallon JR
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):554-7. PubMed ID: 1102233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
    Sigsgaard T; Herrstedt J; Andersen LJ; Havsteen H; Langer SW; Kjaerbøl AG; Lund H; Kjaer M; Dombernowsky P
    Br J Cancer; 1999 May; 80(3-4):412-8. PubMed ID: 10408847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of alizapride and metopimazine (author's transl)].
    Casanova P; Girard D
    Sem Hop; 1982 Feb; 58(6):345-8. PubMed ID: 6280300
    [No Abstract]   [Full Text] [Related]  

  • 16. Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy.
    Sigsgaard T; Herrstedt J; Handberg J; Kjaer M; Dombernowsky P
    J Clin Oncol; 2001 Apr; 19(7):2091-7. PubMed ID: 11283143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism and treatment of nausea and vomiting.
    Nagendran T; Nagendran S
    Ala Med; 1990 Nov; 60(5):12-6. PubMed ID: 2291448
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Wickham R
    Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of metopimazine (Vogalene) in the prevention and treatment of postoperative vomiting in ocular surgery. (Apropos of 100 cases)].
    Arnaud B; Sportouch M
    Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):63-8. PubMed ID: 4261213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of nausea nad vomiting in palliative medicine].
    Bausewein C
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.